Prospective evaluation of the breast microbiome and tumor microenvironment-related biomarkers of response to neoadjuvant systemic therapy in triple negative breast cancer.

Darren Dahly

doi:10.1200/jco.2024.42.16_suppl.tps615

Prospective evaluation of the breast microbiome and tumor microenvironment-related biomarkers of response to neoadjuvant systemic therapy in triple negative breast cancer.

Darren Dahly

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	Journal of Clinical Oncology
DOIs	https://doi.org/10.1200/jco.2024.42.16_suppl.tps615
Publication status	Published - 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Breast cancer
Medicine
Oncology
Microbiome
Internal medicine
Biomarker
Neoadjuvant therapy
Cancer
Tumor microenvironment
Prospective cohort study
Bioinformatics
Biology
Biochemistry

Access to Document

10.1200/jco.2024.42.16_suppl.tps615

https://openalex.org/W4399122019Licence: CC BY-NC-ND

Cite this

@article{23c6dc68b9a0446b9763949e2ce5aba1,

title = "Prospective evaluation of the breast microbiome and tumor microenvironment-related biomarkers of response to neoadjuvant systemic therapy in triple negative breast cancer.",

keywords = "Breast cancer, Medicine, Oncology, Microbiome, Internal medicine, Biomarker, Neoadjuvant therapy, Cancer, Tumor microenvironment, Prospective cohort study, Bioinformatics, Biology, Biochemistry",

author = "Darren Dahly",

year = "2024",

doi = "10.1200/jco.2024.42.16\_suppl.tps615",

language = "English",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "Lippincott Williams and Wilkins",

}

TY - JOUR

T1 - Prospective evaluation of the breast microbiome and tumor microenvironment-related biomarkers of response to neoadjuvant systemic therapy in triple negative breast cancer.

AU - Dahly, Darren

PY - 2024

Y1 - 2024

KW - Breast cancer

KW - Medicine

KW - Oncology

KW - Microbiome

KW - Internal medicine

KW - Biomarker

KW - Neoadjuvant therapy

KW - Cancer

KW - Tumor microenvironment

KW - Prospective cohort study

KW - Bioinformatics

KW - Biology

KW - Biochemistry

U2 - 10.1200/jco.2024.42.16_suppl.tps615

DO - 10.1200/jco.2024.42.16_suppl.tps615

M3 - Article

SN - 0732-183X

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

ER -